# Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

> **NCT06856226** · — · RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 88 (estimated)

## Conditions studied

- Leukemia
- Lymphoma
- Hematologic Malignancy

## Interventions

- **OTHER:** Arm 1

## Key facts

- **NCT ID:** NCT06856226
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-04
- **Primary completion:** 2027-12-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06856226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06856226, "Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06856226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*